Aktuellt
SENASTE
Redeye comments on Isofol’s Q1 2022 report, with the company closing in on critical AGENT top-line data. We estimate Isofol will communicate top-line data between late June and late August of this year. We judge that the company’s cash position extends well beyond AGENT top-line data and a potential NDA submission in H2 2022.
LÄS MER
